Journal article · 2017 · Open access

The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents

Edison S. Zuniga, Aaron Korkegian, Steven Mullen, Erik J. Hembre, Paul L. Ornstein, Guillermo S. Cortez, Kallolmay Biswas, Naresh Kumar, Jeffrey W. Cramer, Thierry Masquelin, Philip A. Hipskind, Joshua O. Odingo and 1 more

Bioorganic & Medicinal Chemistry, 25(15), 3922–3946 · Published 19 May 2017 · DOI 10.1016/j.bmc.2017.05.030

Open PDFView at the publisherCite this paper

In brief

“The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents” is a 2017 journal article by Edison S. Zuniga and 12 co-authors, published in Bioorganic & Medicinal Chemistry. OpenAlex counts 60 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Bioorganic & Medicinal Chemistry.

Citations
60
Most cited in
2023 (11)
Field-weighted impact
2.09
References
17
Authors
13

Abstract

We identified a di-substituted triazolopyrimidine with anti-tubercular activity against Mycobacterium tuberculosis. Three segments of the scaffold were examined rationally to establish a structure-activity relationship with the goal of improving potency and maintaining good physicochemical properties. A number of compounds displayed sub-micromolar activity against Mycobacterium tuberculosis with no cytotoxicity against eukaryotic cells. Non-substituted aromatic rings at C5 and a two-carbon chain connecting a terminal aromatic at C7 were preferred features; the presence of NH at C7 and a lack of substituent at C2 were essential for potency. We identified compounds with acceptable metabolic stability in rodent and human liver microsomes. Our findings suggest that the easily-synthesized triazolopyrimidines are a promising class of potent anti-tubercular agents and warrant further investigation in our search for new drugs to fight tuberculosis.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zuniga, E. S., Korkegian, A., Mullen, S., Hembre, E. J., Ornstein, P. L., Cortez, G. S., Biswas, K., Kumar, N., Cramer, J. W., Masquelin, T., Hipskind, P. A., Odingo, J. O., & Parish, T. (2017). The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents. Bioorganic & Medicinal Chemistry, 25(15), 3922–3946. https://doi.org/10.1016/j.bmc.2017.05.030

MLA 9

Zuniga, Edison S., et al. “The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents.” Bioorganic & Medicinal Chemistry, vol. 25, no. 15, 2017, pp. 3922–3946. https://doi.org/10.1016/j.bmc.2017.05.030.

Chicago

Zuniga, Edison S., Aaron Korkegian, Steven Mullen, Erik J. Hembre, Paul L. Ornstein, Guillermo S. Cortez, Kallolmay Biswas, et al. 2017. “The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents.” Bioorganic & Medicinal Chemistry 25 (15): 3922–3946. https://doi.org/10.1016/j.bmc.2017.05.030.

Harvard

Zuniga, E. S. et al. (2017) ‘The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents’, Bioorganic & Medicinal Chemistry, 25(15), pp. 3922–3946. doi:10.1016/j.bmc.2017.05.030.

IEEE

E. S. Zuniga et al., “The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents,” Bioorganic & Medicinal Chemistry, vol. 25, no. 15, pp. 3922–3946, 2017, doi: 10.1016/j.bmc.2017.05.030.

BibTeX

@article{zuniga2017synthesis,
  title     = {{The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents}},
  author    = {Zuniga, Edison S. and Korkegian, Aaron and Mullen, Steven and Hembre, Erik J. and Ornstein, Paul L. and Cortez, Guillermo S. and Biswas, Kallolmay and Kumar, Naresh and Cramer, Jeffrey W. and Masquelin, Thierry and Hipskind, Philip A. and Odingo, Joshua O. and Parish, Tanya},
  journal   = {Bioorganic \& Medicinal Chemistry},
  year      = {2017},
  volume    = {25},
  number    = {15},
  pages     = {3922--3946},
  doi       = {10.1016/j.bmc.2017.05.030},
  url       = {https://doi.org/10.1016/j.bmc.2017.05.030}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201711
201877
201999
202055
202188
202255
20231111
202444
202566
202644

Its field-weighted citation impact is 2.09: it has been cited 2.09 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds

  • triazolopyrimidines
  • anti-tubercular agents
  • Mycobacterium tuberculosis
  • structure-activity relationship
  • drug design
  • metabolic stability
  • liver microsomes
  • cytotoxicity

Work with this paper

Most-cited papers in Chemistry

All highly cited Chemistry papers

Questions about this paper

How do I cite this paper in APA style?

Zuniga, E. S., Korkegian, A., Mullen, S., Hembre, E. J., Ornstein, P. L., Cortez, G. S., Biswas, K., Kumar, N., Cramer, J. W., Masquelin, T., Hipskind, P. A., Odingo, J. O., & Parish, T. (2017). The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents. Bioorganic & Medicinal Chemistry, 25(15), 3922–3946. https://doi.org/10.1016/j.bmc.2017.05.030

How many times has this paper been cited?

60 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Bioorganic & Medicinal Chemistry: sign in and open the PDF from this page.

Who wrote this paper?

Edison S. Zuniga, Aaron Korkegian, Steven Mullen, Erik J. Hembre, Paul L. Ornstein, Guillermo S. Cortez, Kallolmay Biswas, Naresh Kumar, Jeffrey W. Cramer, Thierry Masquelin, Philip A. Hipskind, Joshua O. Odingo and 1 more.

What is the DOI of this paper?

10.1016/j.bmc.2017.05.030, permanently at https://doi.org/10.1016/j.bmc.2017.05.030. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.